| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.5 | 0.0007 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.002 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.097 | 0.003 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.15 | 0.004 |